Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
38.65
-0.46 (-1.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bright Minds Biosciences Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Selling, General & Admin | 1.56 | 2.21 | 2.55 | 2.31 | 0.12 | 0.11 |
| Research & Development | 1.84 | 4.98 | 12.18 | 6.31 | 0.35 | 0.13 |
| Operating Expenses | 3.4 | 7.2 | 14.73 | 8.62 | 0.47 | 0.24 |
| Operating Income | -3.4 | -7.2 | -14.73 | -8.62 | -0.47 | -0.24 |
| Currency Exchange Gain (Loss) | 0.04 | 0.01 | 0.01 | 0.15 | - | - |
| Other Non Operating Income (Expenses) | -0.21 | -0.19 | -0.24 | -0.18 | -0.01 | - |
| EBT Excluding Unusual Items | -3.58 | -7.37 | -14.96 | -8.65 | -0.48 | -0.24 |
| Asset Writedown | - | - | -0 | - | - | - |
| Pretax Income | -3.58 | -7.37 | -14.96 | -8.65 | -0.48 | -0.24 |
| Net Income | -3.58 | -7.37 | -14.96 | -8.65 | -0.48 | -0.24 |
| Net Income to Common | -3.58 | -7.37 | -14.96 | -8.65 | -0.48 | -0.24 |
| Shares Outstanding (Basic) | 4 | 4 | 2 | 2 | 1 | 0 |
| Shares Outstanding (Diluted) | 4 | 4 | 2 | 2 | 1 | 0 |
| Shares Change (YoY) | 19.17% | 50.57% | 37.64% | 148.42% | 74.24% | - |
| EPS (Basic) | -0.87 | -1.98 | -6.06 | -4.82 | -0.66 | -0.57 |
| EPS (Diluted) | -0.87 | -1.98 | -6.06 | -4.82 | -0.66 | -0.57 |
| Free Cash Flow | -2.58 | -7.02 | -13.59 | -7.32 | -0.29 | -0.13 |
| Free Cash Flow Per Share | -0.63 | -1.89 | -5.50 | -4.08 | -0.40 | -0.30 |
| EBIT | -3.4 | -7.2 | -14.73 | -8.62 | -0.47 | -0.24 |
Source: S&P Capital IQ. Standard template.
Financial Sources.